A11 Venture
VC Fund
Lucca, Italy
A11 Venture is a VC fund in Lucca focused on E-Commerce and Biotechnology. A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries A11 Venture invests in
Stages A11 Venture invests in
Countries A11 Venture invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $278k–$1.3M
- Pre-Seed
- $734k–$1M
Investment Focus
Industry
- E-Commerce 3 (21%)
- Biotechnology 3 (21%)
- Medical Device 3 (21%)
- Fashion 2 (14%)
- Health Care 2 (14%)
Stage
- Seed 9 (64%)
- Pre-Seed 2 (14%)
- Series A 1 (7%)
- Series B 1 (7%)
Country
- Italy 10 (71%)
- United States 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Giovanni Polidori
Founder & Investment Board
|
Founder & Investment Board | Total investments: 1 | Find email | |
Liban Ahmed M Varetti
Founder & Member of the Board of Investment
|
Founder & Member of the Board of Investment | Total investments: 0 | Find email | |
Federico Davini
Investment Board
|
Investment Board | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| AdapTronics is a deep-tech startup that produces adaptive mechatronic devices to make logistics sustainable on Earth and in space. Its adaptive mechatronics technology offers an alternative based on a multifunctional electrostatic membrane that allows the gripping and manipulation of objects of any shape. In addition, it offers a thin-filmtechnology with sensor capabilities that becomes adhesive when electrically activated. | $734.3K / Pre-Seed / Nov 06, 2023 | ||
| Reefilla provides a mobile and predictive charging delivery service for electric vehicles. Reefilla enables people to charge their electric vehicles wherever and whenever they want, without disrupting their daily routine. Reefilla uses 100% green energy, fully electric vans for delivery, and gets its energy from used (second-life) batteries,contributing to net-zero emission by using a circular approach. | $1M / Pre-Seed / Jul 11, 2022 | ||
| Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019. | $635.3K / Seed / Nov 05, 2021 | ||
| Endostart develops and manufactures a new generation of medical devices for gastrointestinal endoscopy. It creates Magnetic Balloon Technology, which improves endoscope performance and allows endoscopists to easily meet quality standards. It was founded in collaboration with CNR, public research institutions, and high-tech suppliers. | $10M / Series B / Jun 07, 2021 | ||
| INTA Systems is a developer of lab-on-a-chip for biomolecular analysis through the combination of nanotech and artificial intelligence. | $418.9K / Seed / Apr 15, 2021 | ||
| Soluzioni innovative per la stampa 3D, manifattura additiva, prototipazione rapida e trattamenti superficiali dei materiali plastici | $278.1K / Seed / Jun 01, 2020 | ||
| Scopri, risparmia, guadagna | $529.3K / Seed / Jul 18, 2019 | ||
| Mindesk is a Real-Time 3D design platform that integrates with existing commercial CAD software to extend its operations to Virtual Reality and Augmented Reality. Mindesk introduces the possibility to design a CAD project from scratch in Virtual Reality. Mindesk platform integrates directly with current CAD solutions and saves precious designsteps: while the majority of VR CAD software commercially available require document exportation, Mindesk enables users to switch from VR to desktop seamlessly while editing the project in real-time on either platform. | $900K / Series A / Mar 12, 2019 | ||
| Endostart develops and manufactures a new generation of medical devices for gastrointestinal endoscopy. It creates Magnetic Balloon Technology, which improves endoscope performance and allows endoscopists to easily meet quality standards. It was founded in collaboration with CNR, public research institutions, and high-tech suppliers. | $1.1M / Seed / Dec 20, 2018 | ||
| Mindesk is a Real-Time 3D design platform that integrates with existing commercial CAD software to extend its operations to Virtual Reality and Augmented Reality. Mindesk introduces the possibility to design a CAD project from scratch in Virtual Reality. Mindesk platform integrates directly with current CAD solutions and saves precious designsteps: while the majority of VR CAD software commercially available require document exportation, Mindesk enables users to switch from VR to desktop seamlessly while editing the project in real-time on either platform. | $732.7K / Seed / May 02, 2017 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does A11 Venture invest in?
A11 Venture invests primarily in E-Commerce, Biotechnology and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 14 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is A11 Venture's check size?
A11 Venture typically joins rounds of $278k–$1.3M at Seed and $734k–$1M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds A11 Venture participates in.
How do I contact A11 Venture?
Public channels for A11 Venture include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at A11 Venture?
The team at A11 Venture includes Giovanni Polidori (Founder & Investment Board), Liban Ahmed M Varetti (Founder & Member of the Board of Investment) and Federico Davini (Investment Board). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
